Aaron Miles serves as Chief Investment Officer of Verano Holdings (Cboe CA: VRNO) (OTCQX:VRNOF), a leading, vertically integrated, U.S. multi-state cannabis company. As one of the largest cannabis companies in the nation, Verano has active operations across 13 states that include 15 cultivation and production facilities and more than 150 dispensaries that operate under the company’s flagship Zen LeafTM and MÜVTM banners.

Over the course of his more than 20 years of financial and capital markets experience, Mr. Miles has served in leadership roles across a variety of Fortune 500 companies and industries. His background and expertise spans investor relations, corporate development, treasury and

communication roles in large and diversified corporations that include Abbott Laboratories, CME Group, Navigant, Tribune Publishing Company, the New York Stock Exchange, and most recently, Cresco Labs.

Among his many accomplishments, Mr. Miles has distinguished himself as a cannabis industry leader in the financial and investor relations space, having notably assisted in taking both Cresco Labs and Verano Holdings public on the Canadian Securities Exchange in 2018 and 2021, respectively. In his current role as Chief Investment Officer, Mr. Miles serves as a member of Verano’s executive leadership team and is active in leading the company’s capital markets and investor relations activities.

A native of Michigan, Mr. Miles graduated from Central Michigan University with a Bachelor of Science degree in Economics and obtained his Master of Science in Finance from Walsh College. He is based in the company’s Chicago headquarters.